Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine for Arrhythmias and MVTWA in Patients With LV Dysfunction
NCT00998218Phase 3Completed
- Sponsor
- Aspirus Health
- Start
- Sep 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ranolazine in ventricular arrhythmia (VA), sudden cardiac death (SCD), sponsored by Aspirus Health. Started Sep 2009; status: completed.
02
Drugs
ranolazine
03
Conditions
ventricular arrhythmia (VA)sudden cardiac death (SCD)
Beyond the preview
Go deeper on NCT00998218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00998218.